Basic Information
ID: ALA3830026
Type: ADME
Description: Drug level in human hepatocytes treated with JNJ-54257099 in presence of CYP2C8 and CYP2C9 inhibitor montelukast by LC-MS/MS analysis
Organism: Homo sapiens
Cell type: Hepatocyte
Activity Charts
Bioactivity
Activity Types for Assay ALA3830026
Drug uptake
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 374.29 | 0.54 | 0.54 |
| 350.22 | -1.94 | -1.94 |